Sleep Outcomes From AWAKE-HF: A Randomized Clinical Trial of Sacubitril/Valsartan Versus Enalapril in Patients With Heart Failure With Reduced Ejection Fraction

SACUBITRIL/VALSARTAN VERSUS ENALAPRIL IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: FINDINGS FROM AWAKE-HF, A RANDOMIZED, CLINICAL TRIAL USING A WEARABLE BIOSENSOR

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(19)31455-x ◽

2019 ◽

Vol 73 (9) ◽

pp. 848

Author(s):

Raj M. Khandwalla ◽

Daniel Grant ◽

Kade Birkeland ◽

J. Thomas Heywood ◽

Kevin McCague ◽

...

Keyword(s):

Heart Failure ◽

Clinical Trial ◽

Ejection Fraction ◽

A randomized clinical trial on the short‐term effects of 12‐week sacubitril/valsartan vs. enalapril on peak oxygen consumption in patients with heart failure with reduced ejection fraction: results from the ACTIVITY‐HF study

European Journal of Heart Failure ◽

10.1002/ejhf.2355 ◽

2021 ◽

Author(s):

Martin Halle ◽

Christoph Schöbel ◽

Ephraim B. Winzer ◽

Peter Bernhardt ◽

Stephan Mueller ◽

...

Keyword(s):

Heart Failure ◽

Clinical Trial ◽

Oxygen Consumption ◽

Ejection Fraction ◽

Peak Oxygen Consumption ◽

Short Term ◽

Short Term Effects

Effect of Natriuretic Peptide-Guided Therapy on Outcomes in High-Risk Patients with Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2017.10.004 ◽

2017 ◽

Vol 23 (11) ◽

pp. 830

Author(s):

G. Michael Felker ◽

Kevin J. Anstrom ◽

Kirkwood F. Adams ◽

Justin A. Ezekowitz ◽

Mona Fiuzat ◽

...

Keyword(s):

Heart Failure ◽

Clinical Trial ◽

High Risk ◽

Ejection Fraction ◽

Natriuretic Peptide ◽

Risk Patients ◽

Guided Therapy

Faculty Opinions recommendation of Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.729075176.793568704 ◽

2019 ◽

Author(s):

Amil Shah

Keyword(s):

Heart Failure ◽

Clinical Trial ◽

High Risk ◽

Ejection Fraction ◽

Cardiovascular Mortality ◽

Risk Patients ◽

Guided Therapy

SLEEP OUTCOMES FROM AWAKE-HF, A RANDOMIZED CLINICAL TRIAL WITH OPEN-LABEL EXTENSION OF SACUBITRIL/VALSARTAN VERSUS ENALAPRIL IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(19)31456-1 ◽

2019 ◽

Vol 73 (9) ◽

pp. 849 ◽

Cited By ~ 1

Author(s):

Robert L. Owens ◽

Kade Birkeland ◽

J. Thomas Heywood ◽

Steven Steinhubl ◽

Jonas Dorn ◽

...

Keyword(s):

Heart Failure ◽

Clinical Trial ◽

Ejection Fraction ◽

Open Label ◽

Open Label Extension

Faculty Opinions recommendation of Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.729075176.793537852 ◽

2017 ◽

Author(s):

Gad Cotter ◽

Olga Milo

Keyword(s):

Heart Failure ◽

Clinical Trial ◽

High Risk ◽

Ejection Fraction ◽

Cardiovascular Mortality ◽

Risk Patients ◽

Guided Therapy

Faculty Opinions recommendation of Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727617606.793568703 ◽

2019 ◽

Author(s):

Amil Shah

Keyword(s):

Heart Failure ◽

Clinical Trial ◽

Iron Deficiency ◽

Ejection Fraction ◽

Exercise Capacity ◽

Oral Iron ◽

Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)

Trials ◽

10.1186/s13063-019-3474-5 ◽

2019 ◽

Vol 20 (1) ◽

Cited By ~ 11

Author(s):

Jesper Jensen ◽

Massar Omar ◽

Caroline Kistorp ◽

Mikael Kjær Poulsen ◽

Christian Tuxen ◽

...

Keyword(s):

Heart Failure ◽

Clinical Trial ◽

Ejection Fraction ◽

Heart Failure Patients

Cost-Effectiveness of Sacubitril/ Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in The Czech Republic: Analysis Based on Patient Characteristics From Randomized Clinical Trial and Local Registries

Value in Health ◽

10.1016/j.jval.2016.09.1759 ◽

2016 ◽

Vol 19 (7) ◽

pp. A652

Author(s):

J Spinar ◽

J Klimes ◽

V Vesela ◽

C Deschaseaux ◽

R Haroun ◽

...

Keyword(s):

Heart Failure ◽

Clinical Trial ◽

Czech Republic ◽

Cost Effectiveness ◽

Chronic Heart Failure ◽

Ejection Fraction ◽

Patient Characteristics ◽

The Czech Republic ◽

Reduced Ejection Fraction

Risk Stratification and Efficacy of Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-021-07178-y ◽

2021 ◽

Author(s):

Yifen Lin ◽

Xiangbin Zhong ◽

Menghui Liu ◽

Shaozhao Zhang ◽

Zhenyu Xiong ◽

...

Keyword(s):

Heart Failure ◽

Clinical Trial ◽

Ejection Fraction ◽

Risk Stratification ◽

Secondary Analysis ◽

Preserved Ejection Fraction ◽